BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, Junker A, Terkelsen CJ, Veien KT, Villadsen AB, Kaltoft A, Tilsted HH, Hansen KN, Aaroe J, Kristensen SD, Hansen HS, Jensen SE, Madsen M, Bøtker HE, Berencsi K, Lassen JF, Christiansen EH. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial. Circ Cardiovasc Interv 2016;9:e003610. [PMID: 27412869 DOI: 10.1161/CIRCINTERVENTIONS.115.003610] [Cited by in Crossref: 68] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, Danse PW, Schotborgh CE, Scholte M, de Man FHAF, Linssen GCM, von Birgelen C. Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial. JAMA Cardiol 2019;4:659-69. [PMID: 31111862 DOI: 10.1001/jamacardio.2019.1776] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 29.0] [Reference Citation Analysis]
2 Kim SH, Kang SH, Lee JM, Chung WY, Park JJ, Yoon CH, Suh JW, Cho YS, Doh JH, Cho JM, Bae JW, Youn TJ, Chae IH. Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial. Catheter Cardiovasc Interv 2020;96:1399-406. [PMID: 31859438 DOI: 10.1002/ccd.28654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
3 Lupi A, Schaffer A, Bongo AS. Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs. J Thorac Dis 2018;10:678-81. [PMID: 29607133 DOI: 10.21037/jtd.2018.01.108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Stevens JR, Zamani A, Osborne JIA, Zamani R, Akrami M. Critical evaluation of stents in coronary angioplasty: a systematic review. Biomed Eng Online 2021;20:46. [PMID: 33964954 DOI: 10.1186/s12938-021-00883-7] [Reference Citation Analysis]
5 Tsujimura T, Ishihara T, Iida O, Hata Y, Toyoshima T, Higashino N, Kurata N, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Matsuda Y, Mano T. Arterial Healing 10 Months After Implantation of an Ultrathin-Strut, Biodegradable-Polymer, Sirolimus-Eluting Stent - An Angioscopic Study. Circ Rep 2021;3:316-23. [PMID: 34136706 DOI: 10.1253/circrep.CR-21-0053] [Reference Citation Analysis]
6 Jambunathan R, Basavanna D, Vani P, Neuss M, Janbandhu P. One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India. World J Cardiol 2019;11:200-8. [PMID: 31523398 DOI: 10.4330/wjc.v11.i8.200] [Reference Citation Analysis]
7 Jain RK, Chakravarthi P, Shetty R, Ramchandra P, Polavarapu RS, Wander GS, Mohan B, Banker DN, Dharmadhikari A, Bansal SS, Jain N, Solanki D, Dhakaan J, Sharma VP, Mohanan PP, Ashokan PK, Manjunath BV, Hiregoudar N, Patil C, Balakrishnan N. One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study. Indian Heart J 2016;68:599-603. [PMID: 27773396 DOI: 10.1016/j.ihj.2016.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
8 Cassese S, Lahmann AL, Joner M. Ultrathin strut biodegradable-polymer sirolimus-eluting stents: being wary or going with the flow? J Thorac Dis 2018;10:688-92. [PMID: 29607135 DOI: 10.21037/jtd.2018.01.118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
9 Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2021;42:2643-54. [PMID: 34002202 DOI: 10.1093/eurheartj/ehab280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ullrich H, Münzel T, Gori T. Coronary Stent Thrombosis- Predictors and Prevention. Dtsch Arztebl Int 2020;117:320-6. [PMID: 32605709 DOI: 10.3238/arztebl.2020.0320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]